1 | the successful closure of | | | | | | | 3 | 0.24% |
2 | successful closure of a | | | | | | | 3 | 0.24% |
3 | who have lost their | | | | | | | 2 | 0.16% |
4 | million in seed financing | | | | | | | 2 | 0.16% |
5 | alithea genomics closes chf | | | | | | | 2 | 0.16% |
6 | genomics closes chf 28 | | | | | | | 2 | 0.16% |
7 | website uses cookies to | | | | | | | 2 | 0.16% |
8 | this website uses cookies | | | | | | | 2 | 0.16% |
9 | extension led by novalis | | | | | | | 2 | 0.16% |
10 | bioscience announces the successful | | | | | | | 2 | 0.16% |
11 | by novalis biotech alithea | | | | | | | 2 | 0.16% |
12 | for the website to | | | | | | | 2 | 0.16% |
13 | patients with rheumatic disease | | | | | | | 2 | 0.16% |
14 | for patients with rheumatic | | | | | | | 2 | 0.16% |
15 | care for patients with | | | | | | | 2 | 0.16% |
16 | have lost their voice | | | | | | | 2 | 0.16% |
17 | rarity bioscience announces the | | | | | | | 2 | 0.16% |
18 | led by novalis biotech | | | | | | | 2 | 0.16% |
19 | the traditional freezedrying process | | | | | | | 2 | 0.16% |
20 | announces the successful closure | | | | | | | 2 | 0.16% |
21 | in life sciences we | | | | | | | 2 | 0.16% |
22 | closure of a €65 | | | | | | | 2 | 0.16% |
23 | of a €65 million | | | | | | | 2 | 0.16% |
24 | €65 million funding round | | | | | | | 2 | 0.16% |
25 | of the final cell | | | | | | | 1 | 0.08% |
26 | this is done in | | | | | | | 1 | 0.08% |
27 | is done in a | | | | | | | 1 | 0.08% |
28 | done in a gentle | | | | | | | 1 | 0.08% |
29 | patents is used to | | | | | | | 1 | 0.08% |
30 | in a gentle manner | | | | | | | 1 | 0.08% |
31 | maximizing the therapeutic quality | | | | | | | 1 | 0.08% |
32 | the therapeutic quality of | | | | | | | 1 | 0.08% |
33 | therapeutic quality of the | | | | | | | 1 | 0.08% |
34 | quality of the final | | | | | | | 1 | 0.08% |
35 | modalityai modalityai inc “modality” | | | | | | | 1 | 0.08% |
36 | the final cell product | | | | | | | 1 | 0.08% |
37 | wwwtrincebiocom modalityai modalityai inc | | | | | | | 1 | 0.08% |
38 | ensures that this is | | | | | | | 1 | 0.08% |
39 | modalityai inc “modality” has | | | | | | | 1 | 0.08% |
40 | inc “modality” has developed | | | | | | | 1 | 0.08% |